Theme: “Research and Evaluation on Bacteriology”

Bacteriology Asia Pacific 2017

Bacteriology Asia Pacific 2017

 

Dear. Colleagues and friends,

As an Organizing Committee Member, it is my great pleasure to welcome you to attend the 6th Annual Bacteriology and Parasitology Meeting during September 13-14, 2017 in the beautiful city of Singapore.

This meeting is a fascinating opportunity for participants to network and allows a close contact between speakers and visitors. This meeting is expected to serve as an excellent debating space for parasitology. Annual Bacteriology and Parasitology Meeting 2017 will focus on the latest advancements in prevention and treatment of Bacterial and Parasitic Infectious diseases.

We are looking forward to see you in Singapore.

With best wishes,

Prof. Eun-Hee Shin

Department of Parasitology and Tropical Medicine,

Seoul National University College of Medicine 

South Korea
 

 

Being recognized as a world-renowned organization, ConferenceSeries Ltd takes pride to introduce the commencement of “6th Annual Bacteriology and Parasitology Meeting" from September 13-14, 2017 at Singapore. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. Conference series LLC’s Bacteriology Asia Pacific 2017 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of bacteriology and immunology under a single roof where networking and global partnering happens for the acceleration of future research.

Conference series LLC through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference series LLC hosts over 400 leading-edge peer reviewed Open Access journals and has organized over 300 scientific conferences all over the world.

ConferenceSeries Ltd welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of Infectious diseases to attend this Bacteriology Conferences, where all the aspects of bacteriology will be discussed under single roof. Bacteriology Asia Pacific 2017 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Bacteriology Asia Pacific 2017 is providing a global platform for research that affords new insights into Microbiology, Molecular bacteriology, Clinical diagnostic bacteriology, Bacterial infections, Industrial bacteriology, Immunology and Infectious Diseases.Infectious diseases are those which are caused by bacteria like E.coli, Salmonella, H.pylori, N.gonorrhoeae, N.meningitidis, S.aureus, and S.bacteria. It includes diseases like pneumonia, meningitis, gastroenteritis, urinary tract infections. 

Why to Attend?

Bacteriology Asia Pacific 2017 highlights the theme “Research and Evaluation on Bacteriology” Which focus on the latest advancements in prevention and treatment cure of Bacterial and Parasitic Infectious diseases.

Bacteriology Asia Pacific 2017 provides two days robust discussions on methods and strategies related to diagnosis, prevention and management of Infectious diseases as well as explore new ideas and concepts on a global scale. This two day event provides a perfect platform for leading scientists, researchers, scholars, practitioners, health care experts, treatment providers, equipment and diagnostic tools manufacturers/vendors, to gain knowledge about the latest advancements in clinical research and health diagnostics within the respective field and also encourages new innovations, research ideas around the globe.

Target Audience

  • Microbiologists
  • Bacteriologists
  • Virologists
  • Parasitologists
  • Mycologists
  • Pathologists
  • Pharmacists
  • Epidemiologists
  • Business Entrepreneurs
  • Health Care Associations & Societies
  • Health Care Professionals
  • Researchers&Fellowship

Track 1: Infectious Diseases

The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination is maintenance of proper hygiene and medicines help in the prevention of infection.

Related Conferences

6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 2: Bacterial Diseases

Bacteria are single-celled microorganisms and the part of microbiological science which encompasses the study of bacteria is known as “Bacteriology”. Major researches in bacteriology over the past years resulted in the development of many useful vaccines. Bacterial ecology is defined as the interaction between bacteria and with their environment. Bacteria play a vital role in the biosphere and certain key processes, such as, the production and oxidation of methane, soil formation, conversion of rock to soil etc. Bacteria are single-celled microorganisms and the part of microbiological science which encompasses the study of bacteria is known as “Bacteriology”. Major researches in bacteriology over the past years resulted in the development of many useful vaccines. The ancestors of present bacteria were said to be first forms of life on earth. Bacterial cells are about 0.5-5.0 micrometres in length. Bacteria exists in different shapes like single celled, diploid (Neisseria), chains (Streptococcus), filaments (Actinobacteria).Bacteria lack membrane bound organelles, contains single loop DNA, it generally undergo conjugation. There are techniques like staining to differentiate Gram positive and Gram negative bacteria. Compared to virus, cost for antibiotics is low still 700 million infections were found every year with the mortality rate of 0.1% normally and in severe conditions it is about 25%.

Related Conferences

5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 3: Bacterial Identification

Accurate and definitive microorganism identification, including bacterial identification and pathogen detection, is essential for correct disease diagnosis, treatment of infection and trace-back of disease outbreaks associated with microbial infections. Bacterial identification is used in a wide variety of applications including microbial forensics, criminal investigations, bio-terrorism threats and environmental studies. Traditional methods of bacterial identification rely on phenotypic identification of the causative organism using gram staining, culture and biochemical methods. However, these methods of bacterial identification suffer from two major drawbacks. First, they can be used only for organisms that can be cultivated in vitro. Second, some strains exhibit unique biochemical characteristics that do not fit into patterns that have been used as a characteristic of any known genus and species. In the past decade or so, molecular techniques have proven beneficial in overcoming some limitations of traditional phenotypic procedures for the detection and characterization of bacterial phenotypes. Several non-culture based methods have emerged in the past 15 years. Real time PCR and microarrays are currently the most commonly employed molecular techniques. Real time PCR is highly sensitive and allows quantitation of bacteria at a species level. Microarray based bacterial identification relies on the hybridization of preamplified bacterial DNA sequences to arrayed species-specific oligonucleotides. Each probe is tagged with a different colored dye which fluoresces upon hybridization.

Related Conferences

4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 4: Bacterial Pathogenesis

Many bacterial Infection  forms biofilms with which its pathogenic nature increases.  The vast majority of these compounds exert their ant biofilm properties through disruption of "quorum sensing," a common means of intercellular communication in bacterial communities that allows coordinated expression of virulence factors and facilitates formation of the complex architecture of mature bacterial biofilms causing zoonotic bacterial diseases. Certain pathogens like Pseudomonas syringe injects virulence in plant host causing diseases. For the Diagnosis of Pathogenic microorganisms Direct Examination and Techniques includes Immunofluorescence, immuno-peroxidase staining, and other immunoassays may detect specific microbial antigens. Genetic probes identify genus- or species-specific DNA or RNA sequences. Forensic evidence involves application of forensic science, technology or "forensics", in order to identify the scene of an accident, specific objects from the trace evidence and often at a crime scene. It is usually submitted to court, which are obtained by scientific methods like by blood test, DNA test. Diagnostic Pathology deals with examination of body tissues and their examination. Microscopical study of abnormal tissue development, disease determination, histopathology of lesions and sometimes post-mortem. It does research on critical diagnosis in surgical pathology.

Related Conferences

35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 5: Bacterial Clinical Studies

Clinical Reviews of infectious diseases and Clinical bacteriology supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. There are types of specimens used clinical pathology. They are blood, urine, sputum, faeces, and other body fluids, in which it deals with health care, especially the diagnosis and treatment of disorders affecting the female reproductive system. The market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World. At present, North America and Europe are the most prominent markets, owing to growing prevalence of various gram-positive bacterial infections and associated diseases. However, Asia-Pacific and some countries in Rest of the World region are expected to show lucrative growth in upcoming period, owing to rapidly growing prevalence and awareness about the diseases caused due to gram-positive bacteria and their chronic effects. The value of microbials and microbial physiology microbials market is projected to increase to $4,456.37 million by 2019 at a CAGR of 15.3% from 2014. The market is expected to show a prominent growth during the forecast period 2014 – 2020.

Related Conferences

3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA,  6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 6: Parasitology

The science dealing with parasites and parasitism is “Parasitology”. The objective is to study the environmental dependence of parasite and host. Parasitic diseases include infections that are due to various parasitic organisms such as protozoa, helminths and arthropods.

Related Conferences

5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA,  6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 7: Parasitic Infection

Parasitic infections are caused by parasites. Few parasites affect the host, grow and give off toxins resulting an infection. Parasitic infections can be spread through various ways such as contaminated water, waste, food, blood etc. Parasites usually enter the body through the mouth or skin. Parasitic infections can be caused by three types of organisms: Protozoa, Helminths. Ectoparasites

Related Conferences

6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 8: Parasitic Worms

A worm classified as a parasite also known as “Helminths”. Parasitic flatworms feed on blood, tissue fluids, or pieces of cells inside the bodies of their hosts. They are often referred to as intestinal worms. The word helminth comes from Greek hélmins, a kind of worm. Helminths are worm-like organisms living in and feeding on living hosts, receiving nourishment and protection while disrupting their hosts' nutrient absorption, causing weakness and disease. Those that live inside the digestive tract are called intestinal parasites. They can live inside humans and other animals. In their adult form, helminths cannot multiply in humans. Helminths are able to survive in their mammalian hosts for many years due to their ability to manipulate the immune response by secreting immunomodulatory products. Helminth ova (or eggs) have a strong shell that protects the eggs against a range of environmental conditions.

Related Conferences

4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 9:  Salmonella

Salmonella is a genus of rod-shaped bacteria of the Enterobacteriaceae family. Salmonella are found worldwide in both cold-blooded and warm-blooded animals, and in the environment. Most people infected with Salmonella develop diarrhea, fever, and abdominal cramps between 12 and 72 hours after infection. Salmonellosis is an infection caused due to Salmonella bacteria. The symptoms include diarrhea, fever, vomiting, and abdominal cramp. The two major diseases caused by salmonella are enteritis that causes osteomyelitis in Children already suffering from sickle cell anemia and typhoid fever along with hypovolemic and septic shocks.

Related Conferences

4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA,  24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 10:  Microbial Genomics

During the past 10 years, genomics and bacterial genomics based approaches have had a profound impact on the field of microbiology and our understanding of microbial species. Because of their larger genome sizes, genome sequencing efforts on fungi and unicellular eukaryotes were slower to get started than projects focused on prokaryotes; however, today there are a number of genome sequences available from both of these groups of organisms that have led to significant improvements in overall sequence annotation and also shed considerable light on novel aspects of their biology. Molecular systems biology is an integrative discipline that seeks to explain the properties and behaviour of complex biological systems in terms of their molecular components and their interactions. Systems biology is the computational and mathematical modeling of complex biological systems. According to the World Health Organization more than 1 million people acquire a sexually transmitted infection (STI) every day and an estimated 500 million people become ill with Chlamydia, gonorrhoea, syphilis or trichomoniasis every year. Approximately 40% of the bacterial species that have been targeted for genome analysis represent important human pathogens. Approximately 40% of the bacterial species based on bacterial pathogenesis that have been targeted for genome analysis represent important human pathogens. Using a whole genome shotgun approach, Tyson et al. (2004) were able to reconstruct two almost complete genome sequences of Leptospirillum group II and Ferro plasma type II and the partial sequence of three other species from a low complexity acid mine drainage biofilm growing underground within a pyrite or body.

Related Conferences

4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 11:  Helicobacter pylori

Helicobacter pylori (see the image below) is a ubiquitous organism that is present in about 50% of the global population. Chronic infection with H pylori causes atrophic and even metaplastic changes in the stomach, and it has a known association with peptic ulcer disease. The most common route of H pylori infection is either oral-to-oral or fecal-to-oral contact.

Related Conferences

4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 12:  Treatment for Infectious Diseases

Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Yeast infections can be primarily treated by sterilisation methods. Parasitic infections can be treated by antiparasitic drugs. Diseases such as cancer can be treated by chemotherapy. Recent techniques have proved that there is no disease that cannot be treated.

Related Conferences

6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 13:  Vaccines and Vaccination

Vaccines are the products that are able to produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism The Centers for Disease Control (CDC) recommends getting 28 doses of 10 vaccines for kids aged 0 to six. No US federal laws mandate vaccination, but all 50 states require certain vaccinations for children entering public schools. Most states offer medical and religious exemptions; and some states allow philosophical exemptions.

Related Conferences

4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 14: Market Analysis

Emerging infectious diseases are those which are caused by bacteria like E.coli, Salmonella, H.pylori, N.gonorrhoeae, N.meningitidis, S.aureus, and S.bacteria. It includes diseases like pneumonia, meningitis, gastroenteritis, urinary tract infections. Case Reports in Clinical Pathology and industrial microbiology supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. There are types of specimens used clinical pathology. They are blood, urine, sputum, faeces, and other body fluids. It deals with women's complaints gynaecological diseases, fertility, pregnancy, '.Pathology (from the Ancient Greek roots of pathos (πάθος), meaning "experience" or "suffering", and -logia (-λογία), "an account of") is a significant component of the causal study of disease and a major field in modern medicine and diagnosis. Pathology is a branch of medical science primarily concerning the examination of organs, tissues, and bodily fluids in order to make a diagnosis of disease.

The drugs used to treat such bacterial infections are called Antibiotics. Especially in US about $ 44.68 billion is expected to reach by 2016.In the period of 2005-2011, there is a growth rate of 6.6% annually. The manufacturing of antibiotics has increased gradually these days, so global demand for aminoglycoside antibiotics is about 79%, pencillin 8%, tetracyclines 4%, erythromycin 7%, streptomycin 1% and chloramphenicol shares about 1% in the antibiotic market globally. Certain bacteria provide benefits to plant including tolerance to temperature stress, salty soils, drought etc. so, there developed microbial seed and plan treatments to confer these stress conditions. It was reported that seed treatment market is trying to reach $ 6 billion by 2020 as it used to be $ 3.6 billion in 2003.

The consumables, equipment and technology markets in the industrial bacteriology and Microbiology industry comes around nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Related Conferences

35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 15: Zoonotic Bacterial Diseases

Zoonotic bacterial diseases are the disease that can be transmitted from animals to humans and vice-versa. the causative organisms can be viruses, bacteria, parasites, and fungi. The infectious diseases that fall under this category are anthrax, brucellosis, bubonic plague, cat-scratch disease, erysipeloid, glanders, leptospirosis, melioidosis, pasteurellosis, pneumonic plague, rat-bite fever, salmonellosis, septicemic plague, sodoku, tularemia and vietnamese tuberculosis.

Related Conferences

35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 5th World Congress on Infection Prevention and Control, Oct 26-27, 2017 Italy, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 6th Annual Bacteriology and Parasitology Meeting, Sep 13-14, 2017 Singapore, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Track 16: General Virology and Viral Evaluation

In the forecast period Asia-Pacific regions of the world are considered as the most promising markets. In Asia Pacific virology market is anticipated to grow at a relatively faster rate throughout the forecast period, remaining the presence of high unmet demand in India and China,. 50% share is held by the hospitals and laboratory segments in the global virology market and it is forecasted to continue through 2025. Viruses are small foreign particles which causes replication only inside the living cells of other organisms. Virus affects all types of living organisms, including animals,plants & microorganisms, and lastly to bacteria’s. They acts as a media for transferring genes between different species.  Viruses are classified into different types.

Generally virology deals with the study of infectious agents such as Virulence, Viruses, Viral Taxonomy, Viral Cultures and Viral Genetics. It is a significant part of both microbiology and pathology. Virology is a part of applied sciences.

Viral evolution is the sub part of virology which is concerned in the evolution of viruses. It is an important aspect of sanitation of viral diseases. They are the largest reservoirs of unexplored genetic diversity on earth.

Importance & Scope:

The bacteria are a group of single-cell microorganisms with prokaryotic cellular configuration. The genetic material (DNA) of prokaryotic cells exists unbound within the living substance of the cells. there is no nuclear membrane, which is that the definitive characteristic of eukaryotic cells like those that make up plants and animals. until recently, bacteria were the only famous kind of prokaryotic cell, and also the discipline of biology associated with their study is called medical specialty. in the 1980's, with the eruption of molecular techniques applied to phylogenesis of life, another cluster of procaryotes was outlined and informally named "archaebacteria". This cluster of procaryotes has since been renamed Archaea and has been awarded biological Domain standing on the extent with bacteria and Eukarya. the present science of medical specialty includes the study of each Domains of prokaryotic cells, however the name "bacteriology" isn't probably to vary to mirror the inclusion of archaea in the discipline. Actually, several archaea have been studied as intensively and as long as their microorganism counterparts, however with the notion that they were bacteria. medical specialty has become more and more necessary to human society. it's emerged as one of the foremost necessary branches of life sciences. As microbes much have an effect on all activities of our life like, food, clothing, shelter, health hygiene etc., biological science has created Brobdingnagian progressive strides in all these fields in very little but a century to boost the standard of our life. Infectious diseases have nearly been conquered by new medication, quality of agricultural crops improved by exploitation techniques of biotechnology, new forms of wines, liquors are produced- of these area unit potential solely because of biological science. of these can create US marvel however our life would have been while not the information of biological science.

Parasitology is that the study of parasites, their hosts, and also the relationship between them. As a biological discipline, the scope of parasitology isn't determined by the organism or setting in question, however by their method of life. this suggests it forms a synthesis of different disciplines.

Why Singapore?

Infectious Diseases still relatively uncommon in Singapore, but the incidence is slowly increasing. While infectious diseases rates in Singapore remain officially low at around 6,000, experts fear the real total could be higher, and will get a lot worse unless attitudes begin to change to a disease many people believe only foreigners can catch. According to the Shinjuku-based National Institute of Infectious Diseases, reported cases of this ancient scourge of mankind appear to be making a comeback. While 831 cases were reported in 2008, the number declined to 621 in 2010. By the end of October this year, the count was up to 2,037 up from 1,670 for all of 2014. Infectious diseases kill more people worldwide than any other single cause. Between October and December of last year, 257 new cases of diseased infections were reported to the ministry, of whom 241 were Japanese and 16 foreign nationals. Of these, for 216 the source of infection was in Singapore, as opposed to 10 overseas. (Sources for the other 31 were uncertain.) Broken down by age segment, the hardest-hit group was those ages 30-39, with 94 cases, followed by 83 cases for ages 20-29, and 59 cases for ages 40-49. CDC in Singapore community battled smallpox, plague, diphtheria, thyroid, cholera and malaria in the early 1900s, to HIV, Nipah virus, SARS and the threats of a flu pandemic in recent years. As we advance into its next century, our plans for the CDC remain the same – for it to continue its vital role and function in Singapore's public health system, with emphasis on research, training and education.

Major Associations around Asia Pacific:

  • The Society of Infectious Diseases (Singapore)
  • Asia Pacific Society of Infection Control
  • Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI)
  • The Infectious Diseases Society of Taiwan (IDST)
  • Chinese Society of Tropical Medicine and Parasitology, Chinese Medical Association
  • The Japanese Association for Infectious Diseases
  • Philippine Society for Microbiology and Infectious Diseases
  • Pediatric Infectious Disease Society of Thailand (PIDST)

Major Associations around the Globe

  • Infectious Diseases Society of America: IDSA
  • International Society for Infectious Diseases: ISID
  • Society of Infectious Diseases Pharmacists
  • American Society for Microbiology

Market Analysis:

The infectious disease nosology market is expected to grow at CAGR of seven.9% to achieve $18,156.2 million by a pair of019 from $12,422.8 million in 2014. Increase in governmental funding for diagnoses of infectious diseases, growing prevalence rate of infectious diseases, and also the development of extremely advanced speedy diagnostic tests for higher management of infectious diseases area unit major factors driving the growth of world market.

The drugs used to treat such bacterial infections are called Antibiotics. Especially in US about $ 44.68 billion is expected to reach by 2017.In the period of 2005-2011, there is a growth rate of 6.6% annually. The manufacturing of antibiotics has increased gradually these days, so global demand for aminoglycoside antibiotics is about 79%, pencillin 8%, tetracyclines 4%, erythromycin 7%, streptomycin 1% and chloramphenicol shares about 1% in the antibiotic market globally. The consumables, equipment and technology markets in the microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Geographically, the infectious disease nosology market is dominated by North America, followed by Europe. However, the Asia-Pacific region is expected to grow at the best CAGR of nine.9% throughout the forecast amount. This growth is attributed to the growing prevalence of infectious disease (tuberculosis, hepatitis and HIV) in countries like China, India, Japan and Australia. Besides these, varied awareness programs concerning prevention of infectious disease area unit conducted in countries like Singapore, Australia and Asian country.

Major players operating in the global infectious disease nosology market area unit Roche nosology (Switzerland), bioMerieux (France), Bio-Rad Laboratories (U.S.), Becton and poet & Co. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Especially in us regarding $ forty four.68 billion is expected to achieve by 2016.In the amount of 2005-2011, there's a growth rate of half dozen.6% annually. The manufacturing of antibiotics has exaggerated step by step currently, therefore global demand for aminoglycoside antibiotics is regarding seventy nine, pencillin 8 May 1945, tetracyclines four wheel drive, antibiotic seven-membered, antibiotic one hundred and twenty fifth and antibiotic drug shares regarding 125th in the antibiotic market globally. sure bacteria give advantages to plant including tolerance to temperature stress, salty soils, drought etc. so, there developed microbic seed and plan treatments to confer these stress conditions. it absolutely was reported that seed treatment market is making an attempt to achieve $ half dozen billion by 2020 as it accustomed be $ three.6 billion in 2003.

The consumables, equipment and technology markets in the Bacteriology and Microbiology industry comes around nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Funding for Bacteriology Research: TDR, the Special Programme for Research and Training in Tropical Diseases, is a global programme of scientific collaboration that helps facilitate, support and influence efforts to combat diseases of poverty. It is hosted at the World Health Organization (WHO), and is sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and WHO. The vision is that it will improve the health and well-being of those burdened by infectious diseases of poverty and to foster an effective global research effort on infectious diseases of poverty and promote the translation of innovation to health impact in disease endemic countries. TDR funds specific research projects in diseases of poverty, which cover infectious diseases and the culture and environment that contribute to these problems.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 13-14, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View

Media Partners